{"meta":{"query_hash":"3ca92c1a1149","filters":{"venue":"Ophthalmology times Europe"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/3ca92c1a1149","api":"https://metacan.xera.ac/api/v1/cohort?venue=Ophthalmology+times+Europe"},"results":[{"id":"W1896244164","doi":"","title":"Is Avastin the future","year":2005,"lang":"en","type":"article","venue":"Ophthalmology times Europe","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Macular degeneration; Bevacizumab; Medicine; Ophthalmology; Optometry; Surgery; Chemotherapy","score_opus":0.01727297572105507,"score_gpt":0.30069379916716105,"score_spread":0.283420823446106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1896244164","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016806795,0.38691857,0.00055922294,0.5586703,0.032700635,0.000018463194,0.00031327666,0.00015188778,0.018987017],"genre_scores_gemma":[0.028702766,0.41759154,0.0016175882,0.44060865,0.08354321,0.00010165596,0.00052275107,0.00013100897,0.027180824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840206,0.00043839787,0.00016019272,0.00023933292,0.00049513293,0.0002649247],"domain_scores_gemma":[0.9937814,0.002426845,0.00072227686,0.00025938958,0.0014563911,0.0013536494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055597075,0.00049699197,0.0014454899,0.0009279339,0.0011836777,0.003968868,0.0009718098,0.008156878,0.017453315],"category_scores_gemma":[0.0095934095,0.0003226973,0.0012504994,0.0006848335,0.0026692904,0.007190233,0.0011656621,0.009917373,0.009130361],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012606599,0.0002831215,0.0010746269,0.0009646343,0.00011079512,0.00042876598,0.00013373647,0.00017084648,0.0011455632,0.02757567,0.5602458,0.40660584],"study_design_scores_gemma":[0.000191406,0.00034827302,0.0005297706,0.00082277716,0.000068786336,0.00035796058,0.00020163668,0.00007643294,0.00022642034,0.01476373,0.9823803,0.000032465694],"about_ca_topic_score_codex":0.0013119715,"about_ca_topic_score_gemma":0.0030527927,"teacher_disagreement_score":0.017453315,"about_ca_system_score_codex":0.0016475697,"about_ca_system_score_gemma":0.003774646,"threshold_uncertainty_score":0.05838716},"labels":[],"label_agreement":null}]}